Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Move over, Novartis: Kite and Gilead break into CAR-T market with early axi-cel nod
Move over, Novartis: Kite and Gilead break into CAR-T market with early axi-cel nod
Move over, Novartis: Kite and Gilead break into CAR-T market with early axi-cel nod
Submitted by
admin
on October 19, 2017 - 9:12am
Source:
Fierce Pharma
News Tags:
Gilead Sciences
Kite Pharma
Novartis
CAR-T
FDA
axi-cel
Yescarta
non-Hodgkin's lymphoma
large B-cell lymphoma
Headline:
Move over, Novartis: Kite and Gilead break into CAR-T market with early axi-cel nod
Do Not Allow Advertisers to Use My Personal information
